Bergman, Auchincloss Introduce Bipartisan Bill to Protect Community Health Centers and Rural Patients

Today, Reps. Jack Bergman and Jake Auchincloss introduced the Community Health Center Drug Pricing Protection Act to protect Community Health Centers and rural patients from harmful proposed changes to the federal 340B Drug Pricing Program.

Community Health Centers, including Federally Qualified Health Centers (FQHCs), serve medically underserved, low-income, and rural communities while operating on the thinnest margins in the health care system. The 340B Program allows these providers to purchase outpatient drugs at discounted prices and reinvest those savings directly into patient care, ensuring care remains available regardless of a patient’s ability to pay.

Recent efforts by federal regulators and drug manufacturers to shift the 340B Program to a rebate-based model would force health centers to pay full price up front and wait for reimbursement. This approach would strain already limited resources and undermine care for the very patients the program was created to serve.

The Community Health Center Drug Pricing Protection Act would ensure Federally Qualified Health Centers are not forced into rebate-based pricing by prohibiting manufacturers from charging more than the 340B ceiling price at the time of purchase. The legislation protects rural providers, preserves access to care, and keeps faith with Congress’s original intent for the 340B Program.

"Community Health Centers are a lifeline for rural and underserved communities, and the 340B Program must work the way Congress intended,”
said Rep. Bergman. “Forcing these providers to front the full cost of expensive drugs and wait on rebates would put patient care at risk. This bipartisan bill ensures health centers can keep resources where they belong - delivering care to the patients who need it most.”

Rep. Auchincloss said, “The 340B program needs reform, but not on the backs of community health centers. Congress must ensure that both sections 330 and 340 are financially supporting health centers as the pillars of primary care in America.”

“The Community Health Center Drug Pricing Protection Act will provide critical protection for FQHCs from the harmful impacts on our patients and health centers of a 340B rebate-based pricing model,” said Phillip Bergquist, Chief Executive Officer, Michigan Primary Care Association. “A 340B rebate model would disrupt access to needed medications and treatments for our patients and place significant administrative, financial, and operational burdens on health centers. We applaud this effort to preserve the 340B program’s intent of increasing access to affordable medications and defend health centers' ability to utilize the 340B program to support access to essential care for patients.”

“I want to thank Congressman Bergman and Congressman Auchincloss for sponsoring this bill to exempt Community Health Centers from any future 340B rebate pilots. The 340B program is a lifeline for the 34 million patients health centers serve nationwide, and every dollar of savings is reinvested into patient care—helping cover the cost of medications and expanding access to services like dental, vision, and behavioral health. A rebate model would shift financial risk onto safety-net providers who cannot afford to front full drug prices while waiting for reimbursement. That would destabilize community health centers, jeopardize patient care, and undermine the intent of the 340B program,” said Michael Curry, President & CEO, Massachusetts League of Community Health Centers.

“Community Health Centers (CHC) serve 52 million people — including 1 in 3 rural residents — and the 340B program is essential to keeping care within reach for all Americans. Exempting CHCs from any rebate model ensures that every 340B dollar continues to support affordable medications and access for low income and rural communities who rely on us the most. We are grateful to Congressman Jack Bergman for leading this bill that protects the care CHC patients depend on every day,” said Kyu Rhee, MD, MPP, President and CEO, National Association of Community Health Centers.